•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A09019 Summary:

BILL NOA09019
 
SAME ASSAME AS S07171
 
SPONSORGunther
 
COSPNSRLupardo, Barrett
 
MLTSPNSR
 
Add 7.48, Ment Hyg L
 
Requires the commissioner to issue a report examining the health impacts of infectious diseases and blood-borne pathogens on mental illness rates in endemic areas of the state.
Go to top    

A09019 Actions:

BILL NOA09019
 
01/12/2018referred to mental health
03/27/2018reported referred to ways and means
Go to top

A09019 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A9019
 
SPONSOR: Gunther
  TITLE OF BILL: An act to amend the mental hygiene law, in relation to impact studies on infectious diseases   PURPOSE OR GENERAL IDEA OF BILL: Amends the mental hygiene law to provide for a study on the mental health impacts of infectious diseases and blood-borne pathogens.   SUMMARY OF PROVISIONS: Section 1 of the bill amends the mental hygiene law to add a new section 7.48 to provide for an infectious disease and blood-borne pathogen impact study to be conducted by the Office of Mental Health, in conjunc- tion with the Department of Health. Section 2 of the bill provides for the effective date.   JUSTIFICATION: When promoting public health initiatives, health care providers and advocates may not immediately connect the emergence of infectious diseases and blood-borne pathogens with mental illness. However, research has emerged that suggests that these types of infections may play an important role in the development of neuropsychiatric condi- tions, mood disorders, and a variety of mental health conditions in infected patients. In August 2017, the Senate Majority Task Force on Lyme and Tick-Borne Diseases, in conjunction with the Senate Standing Committee on Health, convened a public hearing to discuss the ongoing concerns related to the Lyme and tick-borne disease epidemic in New York. Testimony from public health experts, as well as mental health professionals, noted that there were psychiatric symptoms related to these types of infections that could have long-term impacts on the patient's health as well as standard of living. Given the prevalence of certain infectious diseases in New York State, including Lyme and tick-borne diseases, it is imperative that the State approach this epidemic from a holistic perspective that accounts for the mental health consequences of these types of infections. This informa- tion could be vital to the way in which diagnosis and treatment are approached by health care practitioners, and inform medical debates about the causes of mental illness in infectious disease patients, including organic causes, reaction effects, and drug interactions. As such, this legislation will require that the Office of Mental Health, in conjunction with the Department of Health, conduct an impact study considering how infectious diseases and blood-borne pathogens, including Lyme and tick-borne diseases, may have correlations with mental illness in infected individuals.   PRIOR LEGISLATIVE HISTORY: New bill.   FISCAL IMPLICATIONS FOR STATE AND LOCAL GOVERNMENTS: None.   EFFECTIVE DATE: This act shall take effect immediately.
Go to top

A09019 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          9019
 
                   IN ASSEMBLY
 
                                    January 12, 2018
                                       ___________
 
        Introduced  by M. of A. GUNTHER -- read once and referred to the Commit-
          tee on Mental Health
 
        AN ACT to amend the mental hygiene law, in relation to impact studies on
          infectious diseases
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  The mental hygiene law is amended by adding a new section
     2  7.48 to read as follows:
     3  § 7.48 Infectious disease and blood-borne pathogen impact study.
     4    (a) The office, in conjunction with the commissioner of health,  shall
     5  issue  a  report  examining  the  mental  health  impacts  of infectious
     6  diseases and blood-borne pathogens on mental illness  rates  in  endemic
     7  areas of the state. Such report shall include but not be limited to:
     8    (1) Considerations of how Lyme, tick-borne illnesses, and other blood-
     9  borne  pathogens  or  vector-borne  diseases  may have correlations with
    10  mental illness in infected individuals;
    11    (2) Populations at-risk including those individuals  with  occupations
    12  outdoors and/or increased exposure to vectors;
    13    (3)  Diagnostic indicators of mental illness that can be used as guid-
    14  ance for healthcare providers and mental health practitioners;
    15    (4) Historical considerations of infection rates  and  mental  illness
    16  indicators  that  may  have  gone undiagnosed or misdiagnosed in endemic
    17  areas; and
    18    (5) Recommendations for intervention and coordinated care for individ-
    19  uals who exhibit mental illness symptoms as well as those who have  both
    20  physical and mental health indicators.
    21    (b)  Such  report shall be submitted to the temporary president of the
    22  senate and the speaker of the assembly no later than October first,  two
    23  thousand  nineteen. The office and the commissioner of health may engage
    24  stakeholders in the compilation of the report, including but not limited
    25  to, medical research institutions,  health  care  practitioners,  mental
    26  health providers, county and local government, and advocates.
    27    § 2. This act shall take effect immediately.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD13692-03-7
Go to top